AccuVis Bio and Norgen Biotek Corp. Announced a Supply and Collaborative Partnership Agreement

 

 

January, 2013 | Abu Dhabi, UAE. 

Abu Dhabi, UAE. January, 30 /CNW/ - AccuVis Bio and Norgen Biotek Corp. today announced a supply and collaborative partnership agreement. According to the terms of the agreement, AccuVis Bio will be the exclusive representative of Norgen Biotek throughout the Middle East and Norgen will enable AccuVis Bio to manufacture bioconsumable kits for the Middle Eastern Market. Furthermore, both companies will work together on the development of an HIV molecular diagnostic kit for use in resource limited areas. 

 

Norgen Biotek makes best-in-class products for nucleic acid and protein sample preparation, and has recognized that high quality sample preparation is the key to high quality diagnostics. Norgen recently launched a line of diagnostic products for research use that includes kits for the diagnosis of human pathogens, plant pathogens and food-borne pathogens. Now, with this new relationship between Norgen Biotek and AccuVis Bio, Norgen will focus on the development of HIV point-of-care human diagnostic kits for use in resource-limited areas, as well as for home use testing. Furthermore, these new technologies will rely on the use of non-invasive urine-based specimens for ease of use and cost reduction. Norgen's purification technology is extremely well suited for use in resource-limited settings, as Norgen's resin is able to isolate and concentrate DNA, RNA and proteins from samples without the use of centrifugation or other equipment.

 

"The chance to work closely with Norgen Biotek, a leader in sample preparation, is a wonderful opportunity for AccuVis Bio. Not only will this partnership provide us the knowledge and tools we need to manufacture bioconsumable kits to internationally recognized standards, but will also allow us to work closely with Norgen to carry out ground-breaking research to develop novel urine-based HIV diagnostic tests" said Dr. Abdalla Alnajjar, Chairman of AccuVis Bio.

 

"We are very delighted to have joined talent and resources with AccuVis Bio on this this very important research project. This agreement will help in accelerating the development of such an urgently needed HIV diagnostic kit. The quality of a diagnostic test is only as good as the quality of the sample preparation, and as leaders in sample preparation we are in an ideal position to make first-in-class diagnostics, especially for resource limited areas." said Dr. Haj-Ahmad, President & CEO of Norgen Biotek. "Currently, we produce the leading products for the isolation of high quality RNA, DNA and proteins as well as microorganisms from urine, and therefore we anticipate the development of first-in-class urine-based diagnostic tests for the detection of HIV in resource limited areas, as well as for home use." Added Dr. Haj-Ahmad.

 

About Norgen Biotek Corp.

Norgen Biotek, an ISO 13485:2003, ISO 9001:2008 and ISO 15189:2007 registered company, is a rapidly growing Canadian biotech company committed to providing innovative products and services to the life sciences and pharmaceutical industry. Certification to all three of these ISO standards strengthens Norgen's commitment to uphold the highest quality in manufacturing best-in-class products for sample preparation and molecular diagnostics, as well as commitment to providing highly competent R&D and diagnostic testing services. For further information contact: 

Dr. Yousef Haj-Ahmad, President & CEO, Norgen Biotek Corp.,
Phone: (905) 227-8848;
Fax: (905) 227-1061;
Email:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it. " style="color: rgb(0, 74, 151); text-decoration: initial;"> This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

 

About AccuVis Bio.

AccuVis Bio is a UAE-based biotechnology company developing proprietary products and services for the biotechnology and life science communities throughout the Middle East. AccuVis Bio is supported by the Arab Science and Technology Foundation, and is the first of its kind to develop and manufacture purification kits as well as diagnostic kits. 

For further information contact:
Dr. Abdalla Alnajjar, Chairman of AccuVis Bio 
Phone: 971-(50)-462-2626
Fax: 
Email:  This e-mail address is being protected from spambots. You need JavaScript enabled to view it. " style="color: rgb(0, 74, 151); text-decoration: initial;"> This e-mail address is being protected from spambots. You need JavaScript enabled to view it.